FDA Clearance Tracker · P980031
INTACS PRESCRIPTION INSERTS/INTACS CORNEAL IMPLANTS
Last checked: Nov 19, 2026Latest source record: Apr 9, 1999 (this decision)Source: openFDAMethods & limitations
Decided
Apr 9, 1999
Approved
Time to decision
269 days
Received Jul 14, 1998. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P980031
- Device name
- INTACS PRESCRIPTION INSERTS/INTACS CORNEAL IMPLANTS
- Applicant
- Addition Technology
- Applicant location
- Lombard, IL
- Received
- Jul 14, 1998
- Decided
- Apr 9, 1999
- Decision
- Approved
- Supplements
- 13 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Implant, corneal, refractive (LQE)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
This device is indicated for the reduction or elimination of mild myopia (-2.00 to -3.00 diopters spherical equivalent at the spectacle plane) in patients: who are 21 yrs of age or older; with documented stability of refraction as demonstrated by a change of less than or equal to 0.50D for at least 12 months prior to the preoperative examination; and where the astigmatic components are +1.00D or less.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code LQE (Implant, corneal, refractive).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Addition Technology
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.